Exhibit 99.1
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
| | As of | |
| | | March 31, 2024 | | | | September 30, 2023 | |
ASSETS | | | | | | | | |
CURRENT ASSETS | | | | | | | | |
Cash | | $ | 717,879 | | | $ | 112,751 | |
Short-term investments | | | - | | | | 65 | |
Accounts receivable, net | | | 8,108,271 | | | | 4,602,466 | |
Inventories, net | | | 1,437,180 | | | | 987,287 | |
Advance to suppliers, net | | | 15,414,883 | | | | 15,117,191 | |
Acquisition deposit | | | 1,000,000 | | | | 1,000,000 | |
Prepaid expenses and other current assets | | | 1,583,606 | | | | 2,363,704 | |
TOTAL CURRENT ASSETS | | | 28,261,819 | | | | 24,183,464 | |
| | | | | | | | |
Property, plant and equipment, net | | | 20,613,211 | | | | 21,064,043 | |
Intangible assets, net | | | 992,544 | | | | 995,227 | |
Right-of-use lease assets, net | | | 199,679 | | | | 312,067 | |
Deferred tax assets, net | | | 12,672 | | | | 1,335 | |
TOTAL ASSETS | | $ | 50,079,925 | | | $ | 46,556,136 | |
| | | | | | | | |
LIABILITIES AND EQUITY | | | | | | | | |
CURRENT LIABILITIES | | | | | | | | |
Short-term loans | | $ | 4,617,414 | | | $ | 2,509,890 | |
Current portion of long-term loans | | | 473,111 | | | | 419,610 | |
Accounts payable | | | 1,284,816 | | | | 1,404,937 | |
Due to related parties | | | 188,640 | | | | 83,380 | |
Taxes payable | | | 2,523,163 | | | | 2,718,687 | |
Deferred revenue | | | 497,937 | | | | 106,514 | |
Accrued expenses and other current liabilities | | | 1,797,826 | | | | 2,140,900 | |
Operating lease liability, current | | | 202,552 | | | | 227,297 | |
TOTAL CURRENT LIABILITIES | | | 11,585,459 | | | | 9,611,215 | |
| | | | | | | | |
Long-term loans | | | 1,176,624 | | | | 871,368 | |
Operating lease liability, noncurrent | | | - | | | | 91,720 | |
TOTAL LIABILITIES | | $ | 12,762,083 | | | $ | 10,574,303 | |
| | | | | | | | |
COMMITMENTS AND CONTINGENCIES | | | | | | | | |
EQUITY | | | | | | | | |
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 14,138,662 and 11,738,662 shares issued and outstanding as of March 31, 2024 and September 30, 2023, respectively | | | 1,414 | | | | 1,174 | |
Additional paid in capital | | | 19,097,652 | | | | 18,088,056 | |
Statutory reserve | | | 2,372,871 | | | | 2,372,871 | |
Retained earnings | | | 18,693,477 | | | | 18,703,996 | |
Accumulated other comprehensive income | | | (3,470,975 | ) | | | (3,681,445 | ) |
TOTAL BON NATURAL LIFE LIMITED SHAREHOLDERS’ EQUITY | | | 36,694,439 | | | | 35,484,652 | |
Non-controlling interest | | | 623,403 | | | | 497,181 | |
TOTAL SHAREHOLDERS’ EQUITY | | | 37,317,842 | | | | 35,981,833 | |
TOTAL LIABILITIES AND EQUITY | | $ | 50,079,925 | | | $ | 46,556,136 | |
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(UNAUDITED)
| | For the six months ended March 31, | |
| | 2024 | | | 2023 | |
REVENUE | | $ | 10,183,553 | | | $ | 14,149,967 | |
COST OF REVENUE | | | (7,215,116 | ) | | | (9,432,619 | ) |
GROSS PROFIT | | | 2,968,437 | | | | 4,717,348 | |
| | | | | | | | |
OPERATING EXPENSES | | | | | | | | |
Selling expenses | | | (103,096 | ) | | | (136,164 | ) |
General and administrative expenses | | | (1,890,452 | ) | | | (1,465,955 | ) |
Research and development expenses | | | (890,384 | ) | | | (129,995 | ) |
Total operating expenses | | | (2,883,932 | ) | | | (1,732,114 | ) |
| | | | | | | | |
INCOME FROM OPERATIONS | | | 84,505 | | | | 2,985,234 | |
| | | | | | | | |
OTHER INCOME (EXPENSES) | | | | | | | | |
Interest income | | | 161 | | | | 8,732 | |
Interest expense | | | (143,747 | ) | | | (178,557 | ) |
Unrealized foreign transaction exchange loss (gain) | | | (2,747 | ) | | | 8,452 | |
Government subsidies | | | 61,081 | | | | 11,916 | |
Income from short-term investments | | | - | | | | - | |
Other income (expenses) | | | 49,683 | | | | (223,044 | ) |
Total other expenses, net | | | (35,569 | ) | | | (372,501 | ) |
| | | | | | | | |
INCOME BEFORE INCOME TAX PROVISION | | | 48,936 | | | | 2,612,733 | |
| | | | | | | | |
INCOME TAX PROVISION | | | (90,734 | ) | | | (510,077 | ) |
| | | | | | | | |
NET (LOSS) INCOME | | | (41,798 | ) | | | 2,102,656 | |
Less: net loss attributable to non-controlling interest | | | (31,279 | ) | | | (17,104 | ) |
NET (LOSS) INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED | | $ | (10,519 | ) | | $ | 2,119,760 | |
| | | | | | | | |
NET (LOSS) INCOME | | $ | (41,798 | ) | | $ | 2,102,656 | |
| | | | | | | | |
OTHER COMPREHENSIVE INCOME | | | | | | | | |
Total foreign currency translation adjustment | | | 367,971 | | | | 1,071,621 | |
TOTAL COMPREHENSIVE INCOME | | | 326,173 | | | | 3,174,277 | |
Less: comprehensive loss attributable to non-controlling interest | | | 126,222 | | | | (17,104 | ) |
COMPREHENSIVE INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED | | $ | 199,951 | | | $ | 3,191,381 | |
| | | | | | | | |
(LOSS) EARNINGS PER SHARE ATTRIBUTABLE TO BON NATURAL LIFE LIMITED | | | | | | | | |
Basic | | $ | (0.00 | ) | | $ | 0.24 | |
Diluted | | $ | (0.00 | ) | | $ | 0.24 | |
| | | | | | | | |
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING | | | | | | | | |
Basic | | | 12,857,018 | | | | 8,918,309 | |
Diluted | | | 12,857,018 | | | | 8,979,243 | |
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
FOR THE SIX MONTHS ENDED MARCH 31, 2024 AND 2023
(UNAUDITED)
| | Common shares | | | Additional paid-in | | | Statutory | | | Retained | | | Accumulated other comprehensive | | | Total shareholders’ | | | Non- controlling | | | Total | |
| | Shares | | | Amount | | | capital | | | reserve | | | earnings | | | loss | | | equity | | | interest | | | equity | |
Balance at September 30, 2022 | | | 8,396,226 | | | $ | 840 | | | $ | 15,711,450 | | | $ | 1,804,116 | | | $ | 14,676,769 | | | $ | (2,631,171 | ) | | $ | 29,562,004 | | | $ | 530,492 | | | $ | 30,092,496 | |
Issuance of ordinary shares in a private placement, net | | | 2,750,000 | | | | 275 | | | | 2,199,725 | | | | | | | | | | | | | | | | 2,200,000 | | | | | | | | 2,220,000 | |
Share-based compensation | | | | | | | | | | | 35,000 | | | | | | | | | | | | | | | | 35,000 | | | | | | | | 35,000 | |
Net income | | | | | | | | | | | | | | | | | | | 2,119,760 | | | | | | | | 2,119,760 | | | | (17,104 | ) | | | 2,102,656 | |
Foreign currency translation adjustment | | | | | | | | | | | | | | | | | | | | | | | 1,071,621 | | | | 1,071,621 | | | | | | | | 1,071,621 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at March 31, 2023 | | | 11,146,226 | | | $ | 1,115 | | | $ | 17,946,175 | | | $ | 1,804,116 | | | $ | 16,796,529 | | | $ | (1,559,550 | ) | | $ | 34,988,384 | | | $ | 513,387 | | | $ | 35,501,771 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at September 30, 2023 | | | 11,738,662 | | | $ | 1,174 | | | $ | 18,088,056 | | | $ | 2,372,871 | | | $ | 18,703,996 | | | $ | (3,681,445 | ) | | $ | 35,484,652 | | | $ | 497,181 | | | $ | 35,981,833 | |
Share-based compensation | | | 2,400,000 | | | | 240 | | | | 1,009,596 | | | | | | | | | | | | | | | | 1,009,836 | | | | | | | | 1,009,836 | |
Net loss | | | | | | | | | | | | | | | | | | | (10,519 | ) | | | | | | | (10,519 | ) | | | (31,279 | ) | | | (41,798 | ) |
Foreign currency translation adjustment | | | | | | | | | | | | | | | | | | | | | | | 210,470 | | | | 210,470 | | | | 157,501 | | | | 367,971 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at March 31, 2024 | | | 14,138,662 | | | $ | 1,414 | | | $ | 19,097,652 | | | $ | 2,372,871 | | | $ | 18,693,477 | | | $ | (3,470,975 | ) | | $ | 36,694,439 | | | $ | 623,403 | | | $ | 37,317,842 | |
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| | For the six months ended March 31, | |
| | 2024 | | | 2023 | |
Cash flows from operating activities | | | | | | | | |
Net (loss) income | | $ | (41,798 | ) | | $ | 2,102,656 | |
Adjustments to reconcile net income to cash provided by operating activities | | | | | | | | |
Allowance for doubtful accounts | | | 21,441 | | | | - | |
Depreciation and amortization | | | 686,038 | | | | 282,888 | |
Inventory reserve | | | 58,349 | | | | 105,314 | |
Deferred income tax | | | (11,345 | ) | | | (25,749 | ) |
Amortization of operating lease right-of-use assets | | | 115,882 | | | | 114,179 | |
Share-based compensation | | | 1,009,836 | | | | 35,000 | |
Unrealized foreign currency exchange loss (gain) | | | 2,747 | | | | (8,452 | ) |
Changes in operating assets and liabilities: | | | | | | | | |
Accounts receivable | | | (3,464,205 | ) | | | (2,198,450 | ) |
Inventories | | | (498,736 | ) | | | (124,601 | ) |
Advance to suppliers, net | | | (160,908 | ) | | | (3,353,433 | ) |
Prepaid expenses and other current assets | | | 801,781 | | | | (3,595,458 | ) |
Accounts payable | | | (135,111 | ) | | | 100,386 | |
Operating lease liabilities | | | (120,040 | ) | | | (115,170 | ) |
Taxes payable | | | (224,459 | ) | | | 386,510 | |
Deferred revenue | | | 391,057 | | | | 781,183 | |
Accrued expenses and other current liabilities | | | (314,702 | ) | | | 3,335,205 | |
Net cash used in operating activities | | | (1,884,173 | ) | | | (2,177,992 | ) |
| | | | | | | | |
Cash flows from investing activities | | | | | | | | |
Purchase of property and equipment | | | (693 | ) | | | (15,131 | ) |
Capital expenditures on construction-in-progress | | | - | | | | (2,970 | ) |
Net cash used in investing activities | | | (693 | ) | | | (18,101 | ) |
| | | | | | | | |
Cash flows from financing activities | | | | | | | | |
Net proceeds from issuance of ordinary shares | | | - | | | | 2,200,000 | |
Proceeds from short-term loans | | | 3,619,267 | | | | 259,767 | |
Proceeds from long-term loans | | | 854,514 | | | | - | |
Repayment of short-term loans | | | (1,534,052 | ) | | | (79,165 | ) |
Repayment of long-term loans | | | (508,629 | ) | | | (437,412 | ) |
Proceeds from (repayment of) borrowings from related parties | | | 80,752 | | | | (1,038 | ) |
Repayment of capital lease | | | - | | | | (27,236 | ) |
Net cash provided by financing activities | | | 2,511,853 | | | | 1,914,916 | |
| | | | | | | | |
Effect of changes of foreign exchange rates on cash | | | (21,858 | ) | | | (17,412 | ) |
Net increase (decrease) in cash | | | 605,128 | | | | (298,589 | ) |
Cash, beginning of period | | | 112,751 | | | | 840,861 | |
Cash, end of period | | $ | 717,879 | | | $ | 542,272 | |
| | | | | | | | |
Supplemental disclosure of cash flow information | | | | | | | | |
Cash paid for interest expense | | $ | 143,747 | | | $ | 178,557 | |
Cash paid for income tax | | $ | - | | | $ | 500,251 | |
Supplemental disclosure of non-cash investing and financing activities | | | | | | | | |
Amortization of share-based compensation for initial public offering services | | $ | 24,000 | | | $ | 35,000 | |
Right-of-use assets obtained in exchange for operating lease obligations | | $ | - | | | $ | 458,181 | |